Time course of remnant cholesterol and the risk of heart failure

B. Ziaeian, G.C. Fonarow, Epidemiology and aetiology of heart failure. Nat Rev Cardiol 13(6), 368–378 (2016)

Article  PubMed  PubMed Central  Google Scholar 

T.A. McDonagh, M. Metra, M. Adamo, R.S. Gardner, A. Baumbach, M. Böhm, H. Burri, J. Butler, J. Čelutkienė, O. Chioncel, J. Cleland, A. Coats, M.G. Crespo-Leiro, D. Farmakis, M. Gilard, S. Heymans, A.W. Hoes, T. Jaarsma, E.A. Jankowska, M. Lainscak, C. Lam, A.R. Lyon, J. McMurray, A. Mebazaa, R. Mindham, C. Muneretto, M. Francesco Piepoli, S. Price, G. Rosano, F. Ruschitzka, A. Kathrine Skibelund, Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 42(48), 4901–4901 (2021)

Article  PubMed  Google Scholar 

N.L. Bragazzi, W. Zhong, J. Shu, A. Abu Much, D. Lotan, A. Grupper, A. Younis, H. Dai, Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol 28(15), 1682–1690 (2021)

Article  PubMed  Google Scholar 

I. G-Chf, P. Joseph, A. Roy, E. Lonn, S. Störk, J. Floras, L. Mielniczuk, J.L. Rouleau, J. Zhu, A. Dzudie, K. Balasubramanian, K. Karaye, K.F. AlHabib, J.E. Gómez-Mesa, K.R. Branch, A. Makubi, A. Budaj, A. Avezum, T. Wittlinger, G. Ertl, C. Mondo, N. Pogosova, A.P. Maggioni, A. Orlandini, A. Parkhomenko, A. ElSayed, P. López-Jaramillo, A. Grinvalds, A. Temizhan, C. Hage, L.H. Lund, K. Kazmi, F. Lanas, S.K. Sharma, K. Fox, J. McMurray, D. Leong, H. Dokainish, A. Khetan, G. Yonga, K. Kragholm, K. Wagdy Shaker, J.C. Mwita, A.A. Al-Mulla, F. Alla, A. Damasceno, J. Silva-Cardoso, A.L. Dans, K. Sliwa, M. O'Donnell, N. Bazargani, A. Bayés-Genís, T. McCready, J. Probstfield, S. Yusuf, Global variations in heart failure etiology, management, and outcomes. JAMA 329(19), 1650–1661 (2023)

Article  Google Scholar 

H. Wang, K. Chai, M. Du, S. Wang, J.P. Cai, Y. Li, P. Zeng, W. Zhu, S. Zhan, J. Yang, Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart failure 14(10), 008406 (2021)

Article  Google Scholar 

S.J. Greene, J. Butler, Primary prevention of heart failure in patients with type 2 diabetes mellitus. Circulation 139(2), 152–154 (2019)

Article  PubMed  PubMed Central  Google Scholar 

R.S. Velagaleti, J. Massaro, R.S. Vasan, S.J. Robins, W.B. Kannel, D. Levy, Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study. Circulation 120(23), 2345–2351 (2009)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Varbo, B.G. Nordestgaard, Nonfasting triglycerides, low-density lipoprotein cholesterol, and heart failure risk: two cohort studies of 113 554 individuals. Arterioscler Thromb Vasc Biol 38(2), 464–472 (2018)

Article  CAS  PubMed  Google Scholar 

E.P. Navarese, J.G. Robinson, M. Kowalewski, M. Kolodziejczak, F. Andreotti, K. Bliden, U. Tantry, J. Kubica, P. Raggi, P.A. Gurbel, Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. Jama 319(15), 1566–1579 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Preiss, R.T. Campbell, H.M. Murray, I. Ford, C.J. Packard, N. Sattar, K. Rahimi, H.M. Colhoun, D.D. Waters, J.C. LaRosa, P. Amarenco, T.R. Pedersen, M.J. Tikkanen, M.J. Koren, N.R. Poulter, P.S. Sever, P.M. Ridker, J.G. MacFadyen, S.D. Solomon, B.R. Davis, L.M. Simpson, H. Nakamura, K. Mizuno, R.M. Marfisi, R. Marchioli, G. Tognoni, V.G. Athyros, K.K. Ray, A.M. Gotto, M.B. Clearfield, J.R. Downs, J.J. McMurray, The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J 36(24), 1536–1546 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

I. Aim-High, W.E. Boden, J.L. Probstfield, T. Anderson, B.R. Chaitman, P. Desvignes-Nickens, K. Koprowicz, R. McBride, K. Teo, W. Weintraub, Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. New Engl J Med 365(24), 2255–2267 (2011)

Article  Google Scholar 

R. Quispe, S.S. Martin, E.D. Michos, I. Lamba, R.S. Blumenthal, A. Saeed, J. Lima, R. Puri, S. Nomura, M. Tsai, J. Wilkins, C.M. Ballantyne, S. Nicholls, S.R. Jones, M.B. Elshazly, Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J 42(42), 4324–4332 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Liu, J. Zhang, Z. Li, J. Liu, S. Lian, J. Le, Association between remnant cholesterol and heart failure: A prospective cohort study. Front Cardiovasc Med 9, 938647 (2022)

Article  PubMed  PubMed Central  Google Scholar 

T.B. Twickler, G.M. Dallinga-Thie, J.S. Cohn, M.J. Chapman, Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation 109(16), 1918–1925 (2004)

Article  CAS  PubMed  Google Scholar 

S. Wu, Z. Huang, X. Yang, Y. Zhou, A. Wang, L. Chen, H. Zhao, C. Ruan, Y. Wu, A. Xin, K. Li, C. Jin, J. Cai, Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 5(4), 487–493 (2012)

Article  PubMed  Google Scholar 

M. Zheng, X. Zhang, S. Chen, Y. Song, Q. Zhao, X. Gao, S. Wu, Arterial stiffness preceding diabetes: a longitudinal study. Circ Res 127(12), 1491–1498 (2020)

Article  CAS  PubMed  Google Scholar 

C. Ma, M.E. Gurol, Z. Huang, A.H. Lichtenstein, X. Wang, Y. Wang, S. Neumann, S. Wu, X. Gao, Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: A prospective study. Neurology 93(5), e445–e457 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Pottel, P. Delanaye, E. Schaeffner, L. Dubourg, B.O. Eriksen, T. Melsom, E.J. Lamb, A.D. Rule, S.T. Turner, R.J. Glassock, V. De Souza, L. Selistre, K. Goffin, S. Pauwels, C. Mariat, M. Flamant, N. Ebert, Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol, Dial, Transplant 32(3), 497–507 (2017)

CAS  PubMed  Google Scholar 

Y. Fujioka, Y. Ishikawa, Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb 16(3), 145–154 (2009)

Article  CAS  PubMed  Google Scholar 

P. Zemaitis, K. Liu, D.R. Jacobs Jr, M. Cushman, R. Durazo-Arvizu, D. Shoham, W. Palmas, R. Cooper, H. Kramer, Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 9(11), 1922–1929 (2014)

Article  PubMed  PubMed Central  Google Scholar 

Y. Zhang, M.J. Pletcher, E. Vittinghoff, A.M. Clemons, D.R. Jacobs Jr, N.B. Allen, A. Alonso, B.K. Bellows, E.C. Oelsner, A. Zeki Al Hazzouri, D.S. Kazi, S.D. de Ferranti, A.E. Moran, Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events. JAMA Cardiol 6(12), 1406–1413 (2021)

Article  PubMed  PubMed Central  Google Scholar 

H. Zheng, K. Wu, W. Wu, G. Chen, Z. Chen, Z. Cai, Z. Cai, Y. Lan, S. Wu, Y. Chen, Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study. Cardiovasc Diabetol 22(1), 313 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.J. Domanski, X. Tian, C.O. Wu, J.P. Reis, A.K. Dey, Y. Gu, L. Zhao, S. Bae, K. Liu, A.A. Hasan, D. Zimrin, M.E. Farkouh, C.C. Hong, D.M. Lloyd-Jones, V. Fuster, Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. J Am Coll Cardiol 76(13), 1507–1516 (2020)

Article  CAS  PubMed  Google Scholar 

[Chinese guidelines for the diagnosis and treatment of heart failure 2018]. Zhonghua xin xue guan bing za zhi. 2018;46(10):760-789.

O. Castañer, X. Pintó, I. Subirana, A.J. Amor, E. Ros, Á. Hernáez, M.Á. Martínez-González, D. Corella, J. Salas-Salvadó, R. Estruch, J. Lapetra, E. Gómez-Gracia, A.M. Alonso-Gomez, M. Fiol, L. Serra-Majem, E. Corbella, D. Benaiges, J.V. Sorli, M. Ruiz-Canela, N. Babió, L.T. Sierra, E. Ortega, M. Fitó, Remnant cholesterol, Not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol 76(23), 2712–2724 (2020)

Article  PubMed  Google Scholar 

A. Langsted, C.M. Madsen, B.G. Nordestgaard, Contribution of remnant cholesterol to cardiovascular risk. J Intern Med 288(1), 116–127 (2020)

Article  CAS  PubMed  Google Scholar 

R. Wang, H.C. Gerstein, H.G.C. Van Spall, G.Y.H. Lip, I. Olier, S. Ortega-Martorell, L. Thabane, Z. Ye, G. Li, Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus. Eur Heart J Qual Care Clin Outcomes 9, 537–545 (2023)

Article  PubMed  Google Scholar 

H. Cui, Q. Liu, Y. Wu, L. Cao, Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol 21(1), 22 (2022)

Article  CAS  PubMed 

留言 (0)

沒有登入
gif